Skip to main content
Top
Published in: Virology Journal 1/2009

Open Access 01-12-2009 | Research

Cassette deletion in multiple shRNA lentiviral vectors for HIV-1 and its impact on treatment success

Authors: Glen J Mcintyre, Yi Hsin Yu, Anna Tran, Angel B Jaramillo, Allison J Arndt, Michelle L Millington, Maureen P Boyd, Fiona A Elliott, Sylvie W Shen, John M Murray, Tanya L Applegate

Published in: Virology Journal | Issue 1/2009

Login to get access

Abstract

Background

Multiple short hairpin RNA (shRNA) gene therapy strategies are currently being investigated for treating viral diseases such as HIV-1. It is important to use several different shRNAs to prevent the emergence of treatment-resistant strains. However, there is evidence that repeated expression cassettes delivered via lentiviral vectors may be subject to recombination-mediated repeat deletion of 1 or more cassettes.

Results

The aim of this study was to determine the frequency of deletion for 2 to 6 repeated shRNA cassettes and mathematically model the outcomes of different frequencies of deletion in gene therapy scenarios. We created 500+ clonal cell lines and found deletion frequencies ranging from 2 to 36% for most combinations. While the central positions were the most frequently deleted, there was no obvious correlation between the frequency or extent of deletion and the number of cassettes per combination. We modeled the progression of infection using combinations of 6 shRNAs with varying degrees of deletion. Our in silico modeling indicated that if at least half of the transduced cells retained 4 or more shRNAs, the percentage of cells harboring multiple-shRNA resistant viral strains could be suppressed to < 0.1% after 13 years. This scenario afforded a similar protection to all transduced cells containing the full complement of 6 shRNAs.

Conclusion

Deletion of repeated expression cassettes within lentiviral vectors of up to 6 shRNAs can be significant. However, our modeling showed that the deletion frequencies observed here for 6× shRNA combinations was low enough that the in vivo suppression of replication and escape mutants will likely still be effective.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zamore PD, Haley B: Ribo-gnome: the big world of small RNAs. Science 2005, 309: 1519-1524. 10.1126/science.1111444CrossRefPubMed Zamore PD, Haley B: Ribo-gnome: the big world of small RNAs. Science 2005, 309: 1519-1524. 10.1126/science.1111444CrossRefPubMed
2.
go back to reference Hannon GJ, Rossi JJ: Unlocking the potential of the human genome with RNA interference. Nature 2004, 431: 371-378. 10.1038/nature02870CrossRefPubMed Hannon GJ, Rossi JJ: Unlocking the potential of the human genome with RNA interference. Nature 2004, 431: 371-378. 10.1038/nature02870CrossRefPubMed
3.
go back to reference Stevenson M: Therapeutic potential of RNA interference. N Engl J Med 2004, 351: 1772-1777. 10.1056/NEJMra045004CrossRefPubMed Stevenson M: Therapeutic potential of RNA interference. N Engl J Med 2004, 351: 1772-1777. 10.1056/NEJMra045004CrossRefPubMed
4.
go back to reference Naito , Nohtomi , Onogi , Uenishi , Ui-Tei , Saigo , Takebe : Optimal design and validation of antiviral siRNA for targeting HIV-1. Retrovirology 2007, 4: 80. 10.1186/1742-4690-4-80PubMedCentralCrossRefPubMed Naito , Nohtomi , Onogi , Uenishi , Ui-Tei , Saigo , Takebe : Optimal design and validation of antiviral siRNA for targeting HIV-1. Retrovirology 2007, 4: 80. 10.1186/1742-4690-4-80PubMedCentralCrossRefPubMed
5.
go back to reference ter Brake O, Konstantinova P, Ceylan M, Berkhout B: Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol Ther 2006, 14: 883-892. 10.1016/j.ymthe.2006.07.007CrossRefPubMed ter Brake O, Konstantinova P, Ceylan M, Berkhout B: Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol Ther 2006, 14: 883-892. 10.1016/j.ymthe.2006.07.007CrossRefPubMed
6.
go back to reference Mcintyre G, Groneman J, Yu Y, Jaramillo A, Shen S, Applegate T: 96 shRNAs designed for maximal coverage of HIV-1 variants. Retrovirology 2009, 6: 55. 10.1186/1742-4690-6-55PubMedCentralCrossRefPubMed Mcintyre G, Groneman J, Yu Y, Jaramillo A, Shen S, Applegate T: 96 shRNAs designed for maximal coverage of HIV-1 variants. Retrovirology 2009, 6: 55. 10.1186/1742-4690-6-55PubMedCentralCrossRefPubMed
7.
go back to reference Das AT, Brummelkamp TR, Westerhout , Vink M, Madiredjo M, Bernards R, Berkhout B: Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. Journal of Virology 2004, 78: 2601-2605. 10.1128/JVI.78.5.2601-2605.2004PubMedCentralCrossRefPubMed Das AT, Brummelkamp TR, Westerhout , Vink M, Madiredjo M, Bernards R, Berkhout B: Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. Journal of Virology 2004, 78: 2601-2605. 10.1128/JVI.78.5.2601-2605.2004PubMedCentralCrossRefPubMed
8.
go back to reference Boden , Pusch , Lee , Tucker , Ramratnam : Human immunodeficiency virus type 1 escape from RNA interference. Journal of Virology 2003, 77: 11531-11535. 10.1128/JVI.77.21.11531-11535.2003PubMedCentralCrossRefPubMed Boden , Pusch , Lee , Tucker , Ramratnam : Human immunodeficiency virus type 1 escape from RNA interference. Journal of Virology 2003, 77: 11531-11535. 10.1128/JVI.77.21.11531-11535.2003PubMedCentralCrossRefPubMed
9.
go back to reference Westerhout EM, Ooms M, Vink M, Das AT, Berkhout B: HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res 2005, 33: 796-804. 10.1093/nar/gki220PubMedCentralCrossRefPubMed Westerhout EM, Ooms M, Vink M, Das AT, Berkhout B: HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res 2005, 33: 796-804. 10.1093/nar/gki220PubMedCentralCrossRefPubMed
10.
go back to reference Nishitsuji : Effective Suppression of Human Immunodeficiency Virus Type 1 through a Combination of Short- or Long-Hairpin RNAs Targeting Essential Sequences for Retroviral Integration. Journal of Virology 2006, 80: 7658-7666. 10.1128/JVI.00078-06PubMedCentralCrossRefPubMed Nishitsuji : Effective Suppression of Human Immunodeficiency Virus Type 1 through a Combination of Short- or Long-Hairpin RNAs Targeting Essential Sequences for Retroviral Integration. Journal of Virology 2006, 80: 7658-7666. 10.1128/JVI.00078-06PubMedCentralCrossRefPubMed
11.
go back to reference Sabariegos R, Gimenez-Barcons M, Tapia N, Clotet B, Martinez MA: Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs. J Virol 2006, 80: 571-577. 10.1128/JVI.80.2.571-577.2006PubMedCentralCrossRefPubMed Sabariegos R, Gimenez-Barcons M, Tapia N, Clotet B, Martinez MA: Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs. J Virol 2006, 80: 571-577. 10.1128/JVI.80.2.571-577.2006PubMedCentralCrossRefPubMed
12.
go back to reference Ter brake O, Berkhout B: A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs. Journal of RNAi and Gene Silencing 2005, 1: 56-65.PubMedCentralPubMed Ter brake O, Berkhout B: A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs. Journal of RNAi and Gene Silencing 2005, 1: 56-65.PubMedCentralPubMed
13.
go back to reference Wilson JA, Richardson CD: Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region. J Virol 2005, 79: 7050-7058. 10.1128/JVI.79.11.7050-7058.2005PubMedCentralCrossRefPubMed Wilson JA, Richardson CD: Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region. J Virol 2005, 79: 7050-7058. 10.1128/JVI.79.11.7050-7058.2005PubMedCentralCrossRefPubMed
14.
go back to reference Leonard JN, Schaffer DV: Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape. J Virol 2005, 79: 1645-1654. 10.1128/JVI.79.3.1645-1654.2005PubMedCentralCrossRefPubMed Leonard JN, Schaffer DV: Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape. J Virol 2005, 79: 1645-1654. 10.1128/JVI.79.3.1645-1654.2005PubMedCentralCrossRefPubMed
15.
go back to reference Yu JY, Taylor J, DeRuiter SL, Vojtek AB, Turner DL: Simultaneous inhibition of GSK3alpha and GSK3beta using hairpin siRNA expression vectors. Mol Ther 2003, 7: 228-236. 10.1016/S1525-0016(02)00037-0CrossRefPubMed Yu JY, Taylor J, DeRuiter SL, Vojtek AB, Turner DL: Simultaneous inhibition of GSK3alpha and GSK3beta using hairpin siRNA expression vectors. Mol Ther 2003, 7: 228-236. 10.1016/S1525-0016(02)00037-0CrossRefPubMed
16.
go back to reference Schuck S, Manninen A, Honsho M, Fullekrug J, Simons K: Generation of single and double knockdowns in polarized epithelial cells by retrovirus-mediated RNA interference. Proc Natl Acad Sci USA 2004, 101: 4912-4917. 10.1073/pnas.0401285101PubMedCentralCrossRefPubMed Schuck S, Manninen A, Honsho M, Fullekrug J, Simons K: Generation of single and double knockdowns in polarized epithelial cells by retrovirus-mediated RNA interference. Proc Natl Acad Sci USA 2004, 101: 4912-4917. 10.1073/pnas.0401285101PubMedCentralCrossRefPubMed
17.
go back to reference Lee MT, Coburn GA, McClure MO, Cullen BR: Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector. J Virol 2003, 77: 11964-11972. 10.1128/JVI.77.22.11964-11972.2003PubMedCentralCrossRefPubMed Lee MT, Coburn GA, McClure MO, Cullen BR: Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector. J Virol 2003, 77: 11964-11972. 10.1128/JVI.77.22.11964-11972.2003PubMedCentralCrossRefPubMed
18.
go back to reference Anderson J, Akkina R: HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector. AIDS Res Ther 2005, 2: 1. 10.1186/1742-6405-2-1PubMedCentralCrossRefPubMed Anderson J, Akkina R: HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector. AIDS Res Ther 2005, 2: 1. 10.1186/1742-6405-2-1PubMedCentralCrossRefPubMed
19.
go back to reference Gonzalez S, Castanotto D, Li H, Olivares S, Jensen MC, Forman SJ, Rossi JJ, Cooper LJ: Amplification of RNAi--targeting HLA mRNAs. Mol Ther 2005, 11: 811-818. 10.1016/j.ymthe.2004.12.023CrossRefPubMed Gonzalez S, Castanotto D, Li H, Olivares S, Jensen MC, Forman SJ, Rossi JJ, Cooper LJ: Amplification of RNAi--targeting HLA mRNAs. Mol Ther 2005, 11: 811-818. 10.1016/j.ymthe.2004.12.023CrossRefPubMed
20.
go back to reference Saayman , Barichievy , Capovilla , Morris , Arbuthnot , Weinberg , Bowyer : The Efficacy of Generating Three Independent Anti-HIV-1 siRNAs from a Single U6 RNA Pol III-Expressed Long Hairpin RNA. PLoS ONE 2008, 3: e2602. 10.1371/journal.pone.0002602PubMedCentralCrossRefPubMed Saayman , Barichievy , Capovilla , Morris , Arbuthnot , Weinberg , Bowyer : The Efficacy of Generating Three Independent Anti-HIV-1 siRNAs from a Single U6 RNA Pol III-Expressed Long Hairpin RNA. PLoS ONE 2008, 3: e2602. 10.1371/journal.pone.0002602PubMedCentralCrossRefPubMed
21.
go back to reference Liu , Haasnoot , Berkhout : Design of extended short hairpin RNAs for HIV-1 inhibition. Nucleic Acids Research 2008, 35: 5683-5693. 10.1093/nar/gkm596CrossRef Liu , Haasnoot , Berkhout : Design of extended short hairpin RNAs for HIV-1 inhibition. Nucleic Acids Research 2008, 35: 5683-5693. 10.1093/nar/gkm596CrossRef
22.
go back to reference Sano , Li , Nakanishi , Rossi : Expression of Long Anti-HIV-1 Hairpin RNAs for the Generation of Multiple siRNAs: Advantages and Limitations. Mol Ther 2008, 16: 170-177. 10.1038/sj.mt.6300298CrossRefPubMed Sano , Li , Nakanishi , Rossi : Expression of Long Anti-HIV-1 Hairpin RNAs for the Generation of Multiple siRNAs: Advantages and Limitations. Mol Ther 2008, 16: 170-177. 10.1038/sj.mt.6300298CrossRefPubMed
23.
go back to reference Zhu X, Santat LA, Chang MS, Liu J, Zavzavadjian JR, Wall EA, Kivork C, Simon MI, Fraser ID: A versatile approach to multiple gene RNA interference using microRNA-based short hairpin RNAs. BMC Mol Biol 2007, 8: 98. 10.1186/1471-2199-8-98PubMedCentralCrossRefPubMed Zhu X, Santat LA, Chang MS, Liu J, Zavzavadjian JR, Wall EA, Kivork C, Simon MI, Fraser ID: A versatile approach to multiple gene RNA interference using microRNA-based short hairpin RNAs. BMC Mol Biol 2007, 8: 98. 10.1186/1471-2199-8-98PubMedCentralCrossRefPubMed
24.
go back to reference Gou , Weng , Wang , Wang , Zhang , Gao , Chen , Wang , Liu : A novel approach for the construction of multiple shRNA expression vectors. J Gene Med 2007, 9: 751-763. 10.1002/jgm.1080CrossRefPubMed Gou , Weng , Wang , Wang , Zhang , Gao , Chen , Wang , Liu : A novel approach for the construction of multiple shRNA expression vectors. J Gene Med 2007, 9: 751-763. 10.1002/jgm.1080CrossRefPubMed
25.
go back to reference Henry , Vanderwegen , Metselaar , Tilanus , Scholte , Vanderlaan : Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes. Mol Ther 2006, 14: 485-493. 10.1016/j.ymthe.2006.04.012CrossRefPubMed Henry , Vanderwegen , Metselaar , Tilanus , Scholte , Vanderlaan : Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes. Mol Ther 2006, 14: 485-493. 10.1016/j.ymthe.2006.04.012CrossRefPubMed
26.
go back to reference von Laer D, Hasselmann S, Hasselmann K: Impact of gene-modified T cells on HIV infection dynamics. Journal of theoretical biology 2006, 238: 60-77. 10.1016/j.jtbi.2005.05.005CrossRefPubMed von Laer D, Hasselmann S, Hasselmann K: Impact of gene-modified T cells on HIV infection dynamics. Journal of theoretical biology 2006, 238: 60-77. 10.1016/j.jtbi.2005.05.005CrossRefPubMed
27.
go back to reference Naldini L: Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr Opin Biotechnol 1998, 9: 457-463. 10.1016/S0958-1669(98)80029-3CrossRefPubMed Naldini L: Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr Opin Biotechnol 1998, 9: 457-463. 10.1016/S0958-1669(98)80029-3CrossRefPubMed
28.
go back to reference Sinn P, Sauter S, Mccray P: Gene Therapy Progress and Prospects: Development of improved lentiviral and retroviral vectors - design, biosafety, and production. Gene Ther 2005, 12: 1089-1098. 10.1038/sj.gt.3302570CrossRefPubMed Sinn P, Sauter S, Mccray P: Gene Therapy Progress and Prospects: Development of improved lentiviral and retroviral vectors - design, biosafety, and production. Gene Ther 2005, 12: 1089-1098. 10.1038/sj.gt.3302570CrossRefPubMed
29.
go back to reference Bonci D, Cittadini A, Latronico M, Borello U, Aycock J, Drusco A, Innocenzi A, Follenzi A, Lavitrano M, Monti M, et al.: 'Advanced' generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo. Gene Ther 2003, 10: 630-636. 10.1038/sj.gt.3301936CrossRefPubMed Bonci D, Cittadini A, Latronico M, Borello U, Aycock J, Drusco A, Innocenzi A, Follenzi A, Lavitrano M, Monti M, et al.: 'Advanced' generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo. Gene Ther 2003, 10: 630-636. 10.1038/sj.gt.3301936CrossRefPubMed
30.
go back to reference Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Rooney DL, Ihrig MM, McManus M, Gertler FB, et al.: A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 2003, 33: 401-406. 10.1038/ng1117CrossRefPubMed Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Rooney DL, Ihrig MM, McManus M, Gertler FB, et al.: A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 2003, 33: 401-406. 10.1038/ng1117CrossRefPubMed
31.
go back to reference Manjunath N, Wu H, Subramanya S, Shankar P: Lentiviral delivery of short hairpin RNAs. Adv Drug Deliv Rev 2009, 1-14. Manjunath N, Wu H, Subramanya S, Shankar P: Lentiviral delivery of short hairpin RNAs. Adv Drug Deliv Rev 2009, 1-14.
32.
go back to reference Nishitsuji : Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells. Microbes and Infection 2004, 6: 76-85. 10.1016/j.micinf.2003.10.009CrossRefPubMed Nishitsuji : Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells. Microbes and Infection 2004, 6: 76-85. 10.1016/j.micinf.2003.10.009CrossRefPubMed
33.
go back to reference Dickins RA, Hemann MT, Zilfou JT, Simpson DR, Ibarra I, Hannon GJ, Lowe SW: Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat Genet 2005, 37: 1163-1165. 10.1038/ng1105-1163CrossRef Dickins RA, Hemann MT, Zilfou JT, Simpson DR, Ibarra I, Hannon GJ, Lowe SW: Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat Genet 2005, 37: 1163-1165. 10.1038/ng1105-1163CrossRef
34.
go back to reference Levine BL, Humeau LM, Boyer J, MacGregor RR, Rebello T, Lu X, Binder GK, Slepushkin V, Lemiale F, Mascola JR, et al.: Gene transfer in humans using a conditionally replicating lentiviral vector. Proc Natl Acad Sci USA 2006, 103: 17372-17377. 10.1073/pnas.0608138103PubMedCentralCrossRefPubMed Levine BL, Humeau LM, Boyer J, MacGregor RR, Rebello T, Lu X, Binder GK, Slepushkin V, Lemiale F, Mascola JR, et al.: Gene transfer in humans using a conditionally replicating lentiviral vector. Proc Natl Acad Sci USA 2006, 103: 17372-17377. 10.1073/pnas.0608138103PubMedCentralCrossRefPubMed
35.
go back to reference Li MJ, Kim JD, Li SL, Zaia JA, Yee JK, Anderson J, Akkina R, Rossi JJ: Long-Term Inhibition of HIV-1 Infection in Primary Hematopoietic Cells by Lentiviral Vector Delivery of a Triple Combination of Anti-HIV shRNA, Anti-CCR5 Ribozyme, and a Nucleolar-Localizing TAR Decoy. Mol Ther 2005, 12: 900-909. 10.1016/j.ymthe.2005.07.524CrossRefPubMed Li MJ, Kim JD, Li SL, Zaia JA, Yee JK, Anderson J, Akkina R, Rossi JJ: Long-Term Inhibition of HIV-1 Infection in Primary Hematopoietic Cells by Lentiviral Vector Delivery of a Triple Combination of Anti-HIV shRNA, Anti-CCR5 Ribozyme, and a Nucleolar-Localizing TAR Decoy. Mol Ther 2005, 12: 900-909. 10.1016/j.ymthe.2005.07.524CrossRefPubMed
36.
go back to reference Basu VP, Song M, Gao L, Rigby ST, Hanson MN, Bambara RA: Strand transfer events during HIV-1 reverse transcription. Virus Res 2008, 134: 19-38. 10.1016/j.virusres.2007.12.017CrossRefPubMed Basu VP, Song M, Gao L, Rigby ST, Hanson MN, Bambara RA: Strand transfer events during HIV-1 reverse transcription. Virus Res 2008, 134: 19-38. 10.1016/j.virusres.2007.12.017CrossRefPubMed
37.
go back to reference An W, Telesnitsky A: Frequency of direct repeat deletion in a human immunodeficiency virus type 1 vector during reverse transcription in human cells. Virology 2001, 286: 475-482. 10.1006/viro.2001.1025CrossRefPubMed An W, Telesnitsky A: Frequency of direct repeat deletion in a human immunodeficiency virus type 1 vector during reverse transcription in human cells. Virology 2001, 286: 475-482. 10.1006/viro.2001.1025CrossRefPubMed
38.
go back to reference Gilboa E, Mitra SW, Goff S, Baltimore D: A detailed model of reverse transcription and tests of crucial aspects. Cell 1979, 18: 93-100. 10.1016/0092-8674(79)90357-XCrossRefPubMed Gilboa E, Mitra SW, Goff S, Baltimore D: A detailed model of reverse transcription and tests of crucial aspects. Cell 1979, 18: 93-100. 10.1016/0092-8674(79)90357-XCrossRefPubMed
39.
go back to reference Coffin JM: Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses. J Gen Virol 1979, 42: 1-26. 10.1099/0022-1317-42-1-1CrossRefPubMed Coffin JM: Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses. J Gen Virol 1979, 42: 1-26. 10.1099/0022-1317-42-1-1CrossRefPubMed
40.
go back to reference Temin HM: Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation. Proc Natl Acad Sci USA 1993, 90: 6900-6903. 10.1073/pnas.90.15.6900PubMedCentralCrossRefPubMed Temin HM: Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation. Proc Natl Acad Sci USA 1993, 90: 6900-6903. 10.1073/pnas.90.15.6900PubMedCentralCrossRefPubMed
41.
go back to reference Anderson JA, Bowman EH, Hu WS: Retroviral recombination rates do not increase linearly with marker distance and are limited by the size of the recombining subpopulation. J Virol 1998, 72: 1195-1202.PubMedCentralPubMed Anderson JA, Bowman EH, Hu WS: Retroviral recombination rates do not increase linearly with marker distance and are limited by the size of the recombining subpopulation. J Virol 1998, 72: 1195-1202.PubMedCentralPubMed
42.
go back to reference An W, Telesnitsky A: HIV-1 genetic recombination: experimental approaches and observations. AIDS reviews 2002, 4: 195-212.PubMed An W, Telesnitsky A: HIV-1 genetic recombination: experimental approaches and observations. AIDS reviews 2002, 4: 195-212.PubMed
43.
go back to reference Onafuwa A, An W, Robson N, Telesnitsky A: Human immunodeficiency virus type 1 genetic recombination is more frequent than that of Moloney murine leukemia virus despite similar template switching rates. J Virol 2003, 77: 4577-4587. 10.1128/JVI.77.8.4577-4587.2003PubMedCentralCrossRefPubMed Onafuwa A, An W, Robson N, Telesnitsky A: Human immunodeficiency virus type 1 genetic recombination is more frequent than that of Moloney murine leukemia virus despite similar template switching rates. J Virol 2003, 77: 4577-4587. 10.1128/JVI.77.8.4577-4587.2003PubMedCentralCrossRefPubMed
44.
go back to reference Mansky LM, Temin HM: Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 1995, 69: 5087-5094.PubMedCentralPubMed Mansky LM, Temin HM: Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 1995, 69: 5087-5094.PubMedCentralPubMed
45.
go back to reference Brake O, Hooft K, Liu Y, Centlivre M, Jasmijn von Eije K, Berkhout B: Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition. Mol Ther 2008, 16: 557-564. 10.1038/sj.mt.6300382CrossRefPubMed Brake O, Hooft K, Liu Y, Centlivre M, Jasmijn von Eije K, Berkhout B: Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition. Mol Ther 2008, 16: 557-564. 10.1038/sj.mt.6300382CrossRefPubMed
46.
go back to reference Mcintyre G, Groneman J, Tran A, Applegate T: An Infinitely Expandable Cloning Strategy plus Repeat-Proof PCR for Working with Multiple shRNA. PLoS ONE 2008, 3: e3827. 10.1371/journal.pone.0003827PubMedCentralCrossRefPubMed Mcintyre G, Groneman J, Tran A, Applegate T: An Infinitely Expandable Cloning Strategy plus Repeat-Proof PCR for Working with Multiple shRNA. PLoS ONE 2008, 3: e3827. 10.1371/journal.pone.0003827PubMedCentralCrossRefPubMed
47.
go back to reference Paar M, Klein D, Salmons B, Günzburg WH, Renner M, Portsmouth D: Influence of vector design and host cell on the mechanism of recombination and emergence of mutant subpopulations of replicating retroviral vectors. BMC Mol Biol 2009, 10: 8. 10.1186/1471-2199-10-8PubMedCentralCrossRefPubMed Paar M, Klein D, Salmons B, Günzburg WH, Renner M, Portsmouth D: Influence of vector design and host cell on the mechanism of recombination and emergence of mutant subpopulations of replicating retroviral vectors. BMC Mol Biol 2009, 10: 8. 10.1186/1471-2199-10-8PubMedCentralCrossRefPubMed
48.
go back to reference Jetzt AE, Yu H, Klarmann GJ, Ron Y, Preston BD, Dougherty JP: High rate of recombination throughout the human immunodeficiency virus type 1 genome. J Virol 2000, 74: 1234-1240. 10.1128/JVI.74.3.1234-1240.2000PubMedCentralCrossRefPubMed Jetzt AE, Yu H, Klarmann GJ, Ron Y, Preston BD, Dougherty JP: High rate of recombination throughout the human immunodeficiency virus type 1 genome. J Virol 2000, 74: 1234-1240. 10.1128/JVI.74.3.1234-1240.2000PubMedCentralCrossRefPubMed
49.
go back to reference Delviks KA, Pathak VK: Effect of distance between homologous sequences and 3' homology on the frequency of retroviral reverse transcriptase template switching. J Virol 1999, 73: 7923-7932.PubMedCentralPubMed Delviks KA, Pathak VK: Effect of distance between homologous sequences and 3' homology on the frequency of retroviral reverse transcriptase template switching. J Virol 1999, 73: 7923-7932.PubMedCentralPubMed
50.
go back to reference An W, Telesnitsky A: Effects of varying sequence similarity on the frequency of repeat deletion during reverse transcription of a human immunodeficiency virus type 1 vector. J Virol 2002, 76: 7897-7902. 10.1128/JVI.76.15.7897-7902.2002PubMedCentralCrossRefPubMed An W, Telesnitsky A: Effects of varying sequence similarity on the frequency of repeat deletion during reverse transcription of a human immunodeficiency virus type 1 vector. J Virol 2002, 76: 7897-7902. 10.1128/JVI.76.15.7897-7902.2002PubMedCentralCrossRefPubMed
51.
go back to reference Dang Q, Hu WS: Effects of homology length in the repeat region on minus-strand DNA transfer and retroviral replication. J Virol 2001, 75: 809-820. 10.1128/JVI.75.2.809-820.2001PubMedCentralCrossRefPubMed Dang Q, Hu WS: Effects of homology length in the repeat region on minus-strand DNA transfer and retroviral replication. J Virol 2001, 75: 809-820. 10.1128/JVI.75.2.809-820.2001PubMedCentralCrossRefPubMed
52.
go back to reference Pfeiffer JK, Telesnitsky A: Effects of limiting homology at the site of intermolecular recombinogenic template switching during Moloney murine leukemia virus replication. J Virol 2001, 75: 11263-11274. 10.1128/JVI.75.23.11263-11274.2001PubMedCentralCrossRefPubMed Pfeiffer JK, Telesnitsky A: Effects of limiting homology at the site of intermolecular recombinogenic template switching during Moloney murine leukemia virus replication. J Virol 2001, 75: 11263-11274. 10.1128/JVI.75.23.11263-11274.2001PubMedCentralCrossRefPubMed
53.
go back to reference Shen P, Huang HV: Homologous recombination in Escherichia coli: dependence on substrate length and homology. Genetics 1986, 112: 441-457.PubMedCentralPubMed Shen P, Huang HV: Homologous recombination in Escherichia coli: dependence on substrate length and homology. Genetics 1986, 112: 441-457.PubMedCentralPubMed
54.
go back to reference Waldman AS, Liskay RM: Differential effects of base-pair mismatch on intrachromosomal versus extrachromosomal recombination in mouse cells. Proc Natl Acad Sci USA 1987, 84: 5340-5344. 10.1073/pnas.84.15.5340PubMedCentralCrossRefPubMed Waldman AS, Liskay RM: Differential effects of base-pair mismatch on intrachromosomal versus extrachromosomal recombination in mouse cells. Proc Natl Acad Sci USA 1987, 84: 5340-5344. 10.1073/pnas.84.15.5340PubMedCentralCrossRefPubMed
55.
go back to reference Liu , Haasnoot , Brake T, Berkhout , Konstantinova : Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Research 2008, 36: 2811-2824. 10.1093/nar/gkn109PubMedCentralCrossRefPubMed Liu , Haasnoot , Brake T, Berkhout , Konstantinova : Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Research 2008, 36: 2811-2824. 10.1093/nar/gkn109PubMedCentralCrossRefPubMed
56.
57.
go back to reference Reed LJ, Muench H: A simple method of estimating fifty per cent endpoints. The American Journal of Hygiene (now Epidemiology) 1938, 27: 493-497. Reed LJ, Muench H: A simple method of estimating fifty per cent endpoints. The American Journal of Hygiene (now Epidemiology) 1938, 27: 493-497.
58.
go back to reference Hazra R, Mackall C: Thymic function in HIV infection. Current HIV/AIDS reports 2005, 2: 24-28. 10.1007/s11904-996-0005-2CrossRefPubMed Hazra R, Mackall C: Thymic function in HIV infection. Current HIV/AIDS reports 2005, 2: 24-28. 10.1007/s11904-996-0005-2CrossRefPubMed
Metadata
Title
Cassette deletion in multiple shRNA lentiviral vectors for HIV-1 and its impact on treatment success
Authors
Glen J Mcintyre
Yi Hsin Yu
Anna Tran
Angel B Jaramillo
Allison J Arndt
Michelle L Millington
Maureen P Boyd
Fiona A Elliott
Sylvie W Shen
John M Murray
Tanya L Applegate
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2009
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-6-184

Other articles of this Issue 1/2009

Virology Journal 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine